🇺🇸 Daily FSH and GnRH antagonist in United States

Daily FSH and GnRH antagonist (Daily FSH and GnRH antagonist) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Daily FSH and GnRH antagonist in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Daily FSH and GnRH antagonist approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Daily FSH and GnRH antagonist in United States?

Bioroma is the originator. The local marketing authorisation holder may differ — check the official source linked above.